Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovoLumen was a medical technology company that developed advanced interventional tools for the treatment of complex vascular diseases. The company's flagship product was a smart guidewire that integrated Optical Coherence Tomography (OCT) to provide real-time, high-resolution imaging from within the blood vessel. This technology was designed to assist interventional cardiologists and vascular surgeons in navigating and crossing Chronic Total Occlusions (CTO), which are complete blockages of arteries that are difficult to treat with standard techniques. By improving visualization at the tip of the guidewire, NovoLumen aimed to increase the success rate of minimally invasive procedures and reduce the need for more invasive bypass surgeries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novo-Lumen.